Merve Subaşı
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Merve Subaşı has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Muhammed Batur
Urartu Eye Center, 65080 Van, Turkey
3 shared publications - Pınar Güzel Özdemir
Van Yuzuncu Yil Universitesi
1 shared publication - Veysi Yıldız
Department of Ophthalmology, Medical Faculty, Yuzuncu Yıl University, 65090 Van, Turkey
1 shared publication - Yavuz Selim Atan
Van Yüzüncü Yıl University Faculty of Medicine, Department of Psychiatry, Van, Türkiye
1 shared publication
Latest Publications
- Open Access
Comparison of Optical Biometric Parameters Between Phakic and Pseudophakic Eyes: A Retrospective Clinical Study
Background and Objective: To evaluate the effect of pseudophakia on anterior chamber depth and other ocular biometric parameters, and to analyze its relationship with age, sex, and axial length. Materials and Methods: Optical biometry data from 2372 eyes of 1186 patients—each with one pseudophakic and one phakic eye—were retrospectively analyzed using the Lenstar LS 900®. Recorded parameters included axial length (AL), central corneal thickness (CCT), aqueous depth (AD), anterior chamber depth (ACD), lens thickness (LT), keratometry values, and white-to-white distance (WTW). Interocular differences and correlations among variables were statistically assessed. Results: The mean age was 62.8 ± 16.0 years (range, 11–92), and 57.1% were male. Compared with phakic eyes, pseudophakic eyes showed significantly lower AL, WTW, and K1 values (p < 0.01, p < 0.001) and higher CCT, AD, ACD, and astigmatism (AST) values (p < 0.001). No significant difference was observed in K2 (p > 0.05). In both phakic and pseudophakic eyes, males had higher AL, AD, WTW, and ACD and lower K1 and K2 values than females (p < 0.001, p < 0.05). Increasing age was associated with decreased AL and CCT. In phakic eyes, ACD and AD were negatively correlated with age, whereas in pseudophakic eyes, the correlation was positive. Conclusions: Cataract surgery and intraocular lens implantation significantly alter anterior segment structures. Pseudophakia mainly affects ACD and AD, which may be related to postoperative intraocular pressure reduction and may improve the precision of IOL power calculations.
Open AccessComparison of Optical Biometric Parameters Between Phakic and Pseudophakic Eyes: A Retrospective Clinical Study
Background and Objective: To evaluate the effect of pseudophakia on anterior chamber depth and other ocular biometric parameters, and to analyze its relationship with age, sex, and axial length. Materials and Methods: Optical biometry data from 2372 eyes of 1186 patients—each with one pseudophakic and one phakic eye—were retrospectively analyzed using the Lenstar LS 900®. Recorded parameters included axial length (AL), central corneal thickness (CCT), aqueous depth (AD), anterior chamber depth (ACD), lens thickness (LT), keratometry values, and white-to-white distance (WTW). Interocular differences and correlations among variables were statistically assessed. Results: The mean age was 62.8 ± 16.0 years (range, 11–92), and 57.1% were male. Compared with phakic eyes, pseudophakic eyes showed significantly lower AL, WTW, and K1 values (p < 0.01, p < 0.001) and higher CCT, AD, ACD, and astigmatism (AST) values (p < 0.001). No significant difference was observed in K2 (p > 0.05). In both phakic and pseudophakic eyes, males had higher AL, AD, WTW, and ACD and lower K1 and K2 values than females (p < 0.001, p < 0.05). Increasing age was associated with decreased AL and CCT. In phakic eyes, ACD and AD were negatively correlated with age, whereas in pseudophakic eyes, the correlation was positive. Conclusions: Cataract surgery and intraocular lens implantation significantly alter anterior segment structures. Pseudophakia mainly affects ACD and AD, which may be related to postoperative intraocular pressure reduction and may improve the precision of IOL power calculations.
- Open Access
- 1 April 2023
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 53 (2) , 111-119
The Effect of Blindness on Biological Rhythms and the Consequences of Circadian Rhythm Disorder
Körlüğün Biyolojik Ritimler Üzerine Etkisi ve Sirkadiyen Ritim Bozukluğunun Sonuçları
- 1 April 2023
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 53 (2) , 111-119
Open AccessThe Effect of Blindness on Biological Rhythms and the Consequences of Circadian Rhythm Disorder
Körlüğün Biyolojik Ritimler Üzerine Etkisi ve Sirkadiyen Ritim Bozukluğunun Sonuçları
- 25 July 2022
- Published by Academician Publishing
- p. 95-104
Körlük, Sirkadiyen Ritim Uyku Bozukluğu ve Terapötik Yaklaşımlar
Kör insanlarda oküler ışık algısının olmaması, hipotalamustaki suprakiazmatik nükleusta bulunan sirkadiyen saatin senkronizasyonunu bozarak melatonin ve kortizol salgılanması ile uyku-uyanıklık döngülerinin intrinsik periyoduna dönmesine neden olmaktadır. Bu durum, kör bireylerin yarısından fazlasında görülen, gece uykusuzluğu ve gündüz aşırı uyku hali ile karakterize "24 saat olmayan uyku-uyanıklık ritim bozukluğu" başta olmak üzere ciddi sirkadiyen ritim bozukluklarına yol açar. Teşhis sürecinde aktigrafi, uyku günlükleri ve bir melatonin metaboliti olan 6-sülfatoksimelatoninin (aMT6s) biyolojik ölçümleri kullanılarak tanı kesinleştirilir. Tedavi yaklaşımında öncelikle sosyal rutinlerin, beslenme saatlerinin ve fiziksel aktivitelerin düzenlenmesini içeren ilaç dışı, fotik olmayan alternatif zamanlayıcılar (zeitgeber) tercih edilir. İkinci basamakta ise sirkadiyen saati faz kayması yoluyla 24 saatlik döngüye sürüklemek amacıyla kronobiyotik etkili ekzojen melatonin uygulaması veya sirkadiyen fazı etkilediği FDA tarafından onaylanmış güçlü bir melatonin reseptör agonisti olan Tasimelteon kullanılır. İlaçların kullanım zamanlaması ve süresi sirkadiyen saatin başarıyla sıfırlanmasında kritik bir öneme sahiptir. Sonuç olarak, görme engelli bireylerin sosyal ve profesyonel yaşam kalitelerini doğrudan etkileyen bu sirkadiyen ritim bozukluklarında klinik farkındalığın artırılması, erken tanı konulması ve çok boyutlu terapötik yaklaşımların hızla başlatılması hayati bir önem taşımaktadır. The absence of ocular light perception in blind individuals disrupts the synchronization of the circadian clock located in the suprachiasmatic nucleus of the hypothalamus, causing melatonin and cortisol secretion along with sleep-wake cycles to revert to their intrinsic periods. This situation leads to severe circadian rhythm disorders, particularly "non-24-hour sleep-wake rhythm disorder," which is observed in more than half of totally blind individuals and characterized by night insomnia and excessive daytime sleepiness. In the diagnostic process, the diagnosis is confirmed using actigraphy, sleep diaries, and biological measurements of 6-sulfatoxymelatonin (aMT6s), a melatonin metabolite. In the treatment approach, non-pharmacological, non-photic alternative synchronizers (zeitgebers) including the regulation of social routines, meal times, and physical activities are preferred first. In the second line, exogenous melatonin administration with chronobiotic effects or Tasimelteon, a potent melatonin receptor agonist approved by the FDA to affect the circadian phase, is used to entrain the circadian clock to a 24-hour cycle through phase shifting. The timing and duration of medication use are of critical importance in successfully resetting the circadian clock. Consequently, raising clinical awareness, achieving early diagnosis, and rapidly initiating multidimensional therapeutic approaches are of vital importance in these circadian rhythm disorders that directly affect the social and professional life quality of visually impaired individuals.
- 25 July 2022
- Published by Academician Publishing
- p. 95-104
Körlük, Sirkadiyen Ritim Uyku Bozukluğu ve Terapötik Yaklaşımlar
Kör insanlarda oküler ışık algısının olmaması, hipotalamustaki suprakiazmatik nükleusta bulunan sirkadiyen saatin senkronizasyonunu bozarak melatonin ve kortizol salgılanması ile uyku-uyanıklık döngülerinin intrinsik periyoduna dönmesine neden olmaktadır. Bu durum, kör bireylerin yarısından fazlasında görülen, gece uykusuzluğu ve gündüz aşırı uyku hali ile karakterize "24 saat olmayan uyku-uyanıklık ritim bozukluğu" başta olmak üzere ciddi sirkadiyen ritim bozukluklarına yol açar. Teşhis sürecinde aktigrafi, uyku günlükleri ve bir melatonin metaboliti olan 6-sülfatoksimelatoninin (aMT6s) biyolojik ölçümleri kullanılarak tanı kesinleştirilir. Tedavi yaklaşımında öncelikle sosyal rutinlerin, beslenme saatlerinin ve fiziksel aktivitelerin düzenlenmesini içeren ilaç dışı, fotik olmayan alternatif zamanlayıcılar (zeitgeber) tercih edilir. İkinci basamakta ise sirkadiyen saati faz kayması yoluyla 24 saatlik döngüye sürüklemek amacıyla kronobiyotik etkili ekzojen melatonin uygulaması veya sirkadiyen fazı etkilediği FDA tarafından onaylanmış güçlü bir melatonin reseptör agonisti olan Tasimelteon kullanılır. İlaçların kullanım zamanlaması ve süresi sirkadiyen saatin başarıyla sıfırlanmasında kritik bir öneme sahiptir. Sonuç olarak, görme engelli bireylerin sosyal ve profesyonel yaşam kalitelerini doğrudan etkileyen bu sirkadiyen ritim bozukluklarında klinik farkındalığın artırılması, erken tanı konulması ve çok boyutlu terapötik yaklaşımların hızla başlatılması hayati bir önem taşımaktadır. The absence of ocular light perception in blind individuals disrupts the synchronization of the circadian clock located in the suprachiasmatic nucleus of the hypothalamus, causing melatonin and cortisol secretion along with sleep-wake cycles to revert to their intrinsic periods. This situation leads to severe circadian rhythm disorders, particularly "non-24-hour sleep-wake rhythm disorder," which is observed in more than half of totally blind individuals and characterized by night insomnia and excessive daytime sleepiness. In the diagnostic process, the diagnosis is confirmed using actigraphy, sleep diaries, and biological measurements of 6-sulfatoxymelatonin (aMT6s), a melatonin metabolite. In the treatment approach, non-pharmacological, non-photic alternative synchronizers (zeitgebers) including the regulation of social routines, meal times, and physical activities are preferred first. In the second line, exogenous melatonin administration with chronobiotic effects or Tasimelteon, a potent melatonin receptor agonist approved by the FDA to affect the circadian phase, is used to entrain the circadian clock to a 24-hour cycle through phase shifting. The timing and duration of medication use are of critical importance in successfully resetting the circadian clock. Consequently, raising clinical awareness, achieving early diagnosis, and rapidly initiating multidimensional therapeutic approaches are of vital importance in these circadian rhythm disorders that directly affect the social and professional life quality of visually impaired individuals.